Cart
sales@molnova.com
(D-Glu5,D-Trp7·9·10)-Substance P (5-11)
CAS No. 289632-61-7
(D-Glu5,D-Trp7·9·10)-Substance P (5-11)( ——— )
Catalog No. M40438 CAS No. 289632-61-7
(D-Glu5,D-Trp7·9·10)-Substance P (5-11)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(D-Glu5,D-Trp7·9·10)-Substance P (5-11)
-
NoteResearch use only, not for human use.
-
Brief Description(D-Glu5,D-Trp7·9·10)-Substance P (5-11)
-
Description(D-Glu5,D-Trp7·9·10)-Substance P (5-11)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number289632-61-7
-
Formula Weight1111.3
-
Molecular FormulaC57H66N12O10S
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
KRA-533
KRA-533 is a potent KRAS agonist. KRA-533 binds to the GTP/GDP binding pocket in the KRAS protein to prevent GTP cleavage, resulting in the accumulation of constitutively active GTP-bound KRAS that triggers both apoptotic and autophagic cell death pathways in cancer cells.
-
α-ANF(1-28), human
Atrial natriuretic factor (1-28) (human, porcine) exhibits blood pressure lowering activity by increasing sodium and urine excretion. Atrial natriuretic factor (1-28) (human, porcine) inhibits the release of pituitary adrenocorticotropic hormone (ACTH) and beta-endorphin through inhibition of pro-opiomelanocortin (POMC) expression. Atrial natriuretic factor (1-28) (human, porcine) increases cGMP levels in RMIC cells with an IC50 of 1.2 nM.
-
CMPF
CMPF is a microtubule protein inhibitor that can be used to study tumors.
